Terms: = Ovarian cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
15 results:
1. Myeloid-Derived Suppressor Cells (MDSCs) in ovarian cancer-Looking Back and Forward.
Okła K
Cells; 2023 Jul; 12(14):. PubMed ID: 37508575
[TBL] [Abstract] [Full Text] [Related]
2. car-T Cells in the Treatment of ovarian cancer: A Promising Cell Therapy.
Zhang XW; Wu YS; Xu TM; Cui MH
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979400
[TBL] [Abstract] [Full Text] [Related]
3. Human antibodies targeting ENPP1 as candidate therapeutics for cancers.
Chu X; Baek DS; Li W; Shyp T; Mooney B; Hines MG; Morin GB; Sorensen PH; Dimitrov DS
Front Immunol; 2023; 14():1070492. PubMed ID: 36761762
[TBL] [Abstract] [Full Text] [Related]
4. Construction of car-T cells targeting TM4SF1 and its anti-tumor capacity in ovarian cancer.
Shen Y; Liu G; Zhang Q; Tian X; Ouyang L; Zhang L
Immunol Lett; 2023 Mar; 255():1-9. PubMed ID: 36739093
[TBL] [Abstract] [Full Text] [Related]
5. Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with ovarian, Fallopian Tube, and Peritoneal cancer.
Nomoto N; Tate S; Arai M; Iizaka S; Mori C; Sakurai K
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501212
[TBL] [Abstract] [Full Text] [Related]
6. Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy.
Gupta R; Jit BP; Kumar S; Mittan S; Tanwer P; Ray MD; Mathur S; Perumal V; Kumar L; Rath GK; Sharma A
Epigenomics; 2022 Jul; 14(14):865-886. PubMed ID: 35872653
[TBL] [Abstract] [Full Text] [Related]
7. Construction and Characterization of Cadherin 6 (CDH6)-Targeting Chimeric Antigen Receptor (car) Modified T Cells.
Pang L; Ren F; Xu X; Fu L; Wang T; Guo Z
J Environ Pathol Toxicol Oncol; 2022; 41(1):55-71. PubMed ID: 35378004
[TBL] [Abstract] [Full Text] [Related]
8. Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer.
Le Saux O; Ray-Coquard I; Labidi-Galy SI
Semin Cancer Biol; 2021 Dec; 77():127-143. PubMed ID: 32931951
[TBL] [Abstract] [Full Text] [Related]
9. car T Cells Targeting MISIIR for the Treatment of ovarian cancer and Other Gynecologic Malignancies.
Rodriguez-Garcia A; Sharma P; Poussin M; Boesteanu AC; Minutolo NG; Gitto SB; Omran DK; Robinson MK; Adams GP; Simpkins F; Powell DJ
Mol Ther; 2020 Feb; 28(2):548-560. PubMed ID: 31870622
[TBL] [Abstract] [Full Text] [Related]
10. [Postoperative Recurrence of Pancreatic cancer Successfully Treated with the Gemcitabine plus Oxaliplatin Regimen Resulting in Long-Term Survival-ACase Report].
Makino H; Kametaka H; Fukada T; Akiyama T; Saitou M; Tabe S; Okura R; Oya M; Seike K; Yoshitomi H; Miyazaki M
Gan To Kagaku Ryoho; 2019 Jan; 46(1):142-144. PubMed ID: 30765668
[TBL] [Abstract] [Full Text] [Related]
11. Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for ovarian cancer Therapy.
Hung CF; Xu X; Li L; Ma Y; Jin Q; Viley A; Allen C; Natarajan P; Shivakumar R; Peshwa MV; Emens LA
Hum Gene Ther; 2018 May; 29(5):614-625. PubMed ID: 29334771
[TBL] [Abstract] [Full Text] [Related]
12. Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected car T cells is influenced by surface antigen expression level.
Song DG; Ye Q; Poussin M; Chacon JA; Figini M; Powell DJ
J Hematol Oncol; 2016 Jul; 9(1):56. PubMed ID: 27439908
[TBL] [Abstract] [Full Text] [Related]
13. Expression of PKCα, PKCε, and P-gp in epithelial ovarian carcinoma and the clinical significance.
Lili X; Xiaoyu T
Eur J Gynaecol Oncol; 2015; 36(2):181-5. PubMed ID: 26050357
[TBL] [Abstract] [Full Text] [Related]
14. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.
Chen Y; Tang Y; Guo C; Wang J; Boral D; Nie D
Biochem Pharmacol; 2012 Apr; 83(8):1112-26. PubMed ID: 22326308
[TBL] [Abstract] [Full Text] [Related]
15. [cancer associated retinopathy (car). Two clinical cases and review of the literature].
Matus G; Dicato M; Focan C
Rev Med Liege; 2007 Mar; 62(3):166-9. PubMed ID: 17511385
[TBL] [Abstract] [Full Text] [Related]
